FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138162013> ?p ?o ?g. }

• W3138162013 abstract "Background and importance The European Public Assessment Report (EPAR) is a document that summarises the scientific–technical characteristics of drugs. The information that the EPAR should provide is described in the directive 2004/27/CE, but sometimes it is not enough to cover all scenarios in patients in the oncohaematological pharmaceutical care consultation. Aim and objectives To evaluate if the information in the EPAR for oral antineoplastic drugs that are dispensed in the outpatient consultation service (OCS) is enough for the management of these drugs in patients with swallowing problems or with nasogastric tubes. Material and methods We reviewed the EPAR oral antineoplastics drugs dispensed in the OCS. Additionally, articles were searched on Pubmed using the following requests: ‘oral antineoplastic’, ‘swallowing’ and ‘feeding tube’. If the searches did not provide enough information, we contacted the laboratories by telephone. All information was compiled in an Excel table to analyse the results. Results The information in the EPAR about oral administration of 32 cytostatics was reviewed. For 20 drugs, the EPAR indicated that the tablets cannot be crushed, bitten or split, and the whole tablet must be swallowed; for five drugs there was no reference about how to administer it; and for five drugs it specified that there was a possibility of dispersing the tablet and indicated how to do it. The EPAR for two drugs was not found. We performed a bibliographic search of drugs when we did not have enough information (27). Relevant information was found for 11 but information was very limited for 4 (isolated cases of administration outside of what is specified in the EPAR). Finally, for the drugs that we had no information (12), we requested information from 10 laboratories. For five drugs, no additional information was available. Five laboratories told us that they did not advise this type of procedure but that there were isolated cases described in the bibliography. No response was obtained for two drugs. Conclusion and relevance The information collected in the EPAR is insufficient to resolve doubts for an oncohaematological pharmaceutical care consultation in most cases and it is necessary to perform bibliographic searches to obtain quality information. Laboratories should provide all available information and implement trials to evaluate the efficacy of drugs in real practice. References and/or acknowledgements Conflict of interest No conflict of interest" @default.
• W3138162013 created "2021-03-29" @default.
• W3138162013 creator A5023827343 @default.
• W3138162013 creator A5024026695 @default.
• W3138162013 creator A5037349776 @default.
• W3138162013 creator A5059455816 @default.
• W3138162013 creator A5075937719 @default.
• W3138162013 creator A5079951408 @default.
• W3138162013 creator A5091139034 @default.
• W3138162013 date "2021-03-01" @default.
• W3138162013 modified "2023-09-24" @default.
• W3138162013 title "4CPS-283 Oncohaematological pharmaceutical care consultation. Is the information on the European Public Assessment Report of drugs enough?" @default.
• W3138162013 doi "https://doi.org/10.1136/ejhpharm-2021-eahpconf.115" @default.
• W3138162013 hasPublicationYear "2021" @default.
• W3138162013 type Work @default.
• W3138162013 sameAs 3138162013 @default.
• W3138162013 citedByCount "0" @default.
• W3138162013 crossrefType "proceedings-article" @default.
• W3138162013 hasAuthorship W3138162013A5023827343 @default.
• W3138162013 hasAuthorship W3138162013A5024026695 @default.
• W3138162013 hasAuthorship W3138162013A5037349776 @default.
• W3138162013 hasAuthorship W3138162013A5059455816 @default.
• W3138162013 hasAuthorship W3138162013A5075937719 @default.
• W3138162013 hasAuthorship W3138162013A5079951408 @default.
• W3138162013 hasAuthorship W3138162013A5091139034 @default.
• W3138162013 hasBestOaLocation W31381620131 @default.
• W3138162013 hasConcept C19527891 @default.
• W3138162013 hasConcept C199360897 @default.
• W3138162013 hasConcept C2779547435 @default.
• W3138162013 hasConcept C41008148 @default.
• W3138162013 hasConcept C512399662 @default.
• W3138162013 hasConcept C71924100 @default.
• W3138162013 hasConcept C98274493 @default.
• W3138162013 hasConceptScore W3138162013C19527891 @default.
• W3138162013 hasConceptScore W3138162013C199360897 @default.
• W3138162013 hasConceptScore W3138162013C2779547435 @default.
• W3138162013 hasConceptScore W3138162013C41008148 @default.
• W3138162013 hasConceptScore W3138162013C512399662 @default.
• W3138162013 hasConceptScore W3138162013C71924100 @default.
• W3138162013 hasConceptScore W3138162013C98274493 @default.
• W3138162013 hasLocation W31381620131 @default.
• W3138162013 hasOpenAccess W3138162013 @default.
• W3138162013 hasPrimaryLocation W31381620131 @default.
• W3138162013 hasRelatedWork W12313147 @default.
• W3138162013 hasRelatedWork W13176004 @default.
• W3138162013 hasRelatedWork W14624714 @default.
• W3138162013 hasRelatedWork W19557803 @default.
• W3138162013 hasRelatedWork W21469927 @default.
• W3138162013 hasRelatedWork W3837414 @default.
• W3138162013 hasRelatedWork W8245150 @default.
• W3138162013 hasRelatedWork W18081504 @default.
• W3138162013 hasRelatedWork W21294913 @default.
• W3138162013 hasRelatedWork W4379633 @default.
• W3138162013 isParatext "false" @default.
• W3138162013 isRetracted "false" @default.
• W3138162013 magId "3138162013" @default.
• W3138162013 workType "article" @default.